Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
1.
Arch Esp Urol ; 55(7): 792-6, 2002 Sep.
Article in Spanish | MEDLINE | ID: mdl-12380307

ABSTRACT

OBJECTIVE: To evaluate P 53 and c-erb-2 overexpression as a prognostic factor for progression and survival in patients with renal pelvis and ureter tumors. METHODS: Retrospective review of the medical records and pathology/immunohistochemical reports of 61 patients who underwent surgery for upper urinary tract urothelial tumors. Immunohistochemical studies were performed using the STREPTAVIDIN-BIOTIN-PEROXIDASE techniques with a LASAB kit (DAKO). Pearson's Chi square for 2 x 2 contingency tables and residues analysis were used for non continuous variables, with a confidence level of p < 0.05. COX multivariate analysis and survival curves were used for multiple variables association. RESULTS: A higher P 53 overexpression was related with tumour dependent death (p < 0.001). These patients have their long term survival compromised. C-erb-2 overexpression is not statistically related to either proliferation or cancer specific death in upper urinary tract urothelial tumors. CONCLUSIONS: In our series P53 overexpression has prognostic value in upper urinary tract urothelial tumors, but c-erb-2 did has not prognostic value.


Subject(s)
Carcinoma, Transitional Cell/metabolism , Gene Expression Regulation, Neoplastic , Kidney Neoplasms/metabolism , Kidney Pelvis/metabolism , Neoplasm Proteins/biosynthesis , Receptor, ErbB-2/biosynthesis , Tumor Suppressor Protein p53/biosynthesis , Ureteral Neoplasms/metabolism , Adult , Aged , Aged, 80 and over , Carcinoma, Transitional Cell/genetics , Carcinoma, Transitional Cell/mortality , Carcinoma, Transitional Cell/pathology , Disease Progression , Female , Genes, erbB-2 , Genes, p53 , Humans , Immunoenzyme Techniques , Kidney Neoplasms/genetics , Kidney Neoplasms/mortality , Kidney Neoplasms/pathology , Kidney Pelvis/pathology , Male , Middle Aged , Neoplasm Proteins/genetics , Prognosis , Proportional Hazards Models , Retrospective Studies , Survival Analysis , Ureteral Neoplasms/mortality , Ureteral Neoplasms/pathology
2.
Arch. esp. urol. (Ed. impr.) ; 55(7): 792-796, sept. 2002.
Article in Es | IBECS | ID: ibc-13291

ABSTRACT

Objetivos: Valorar la sobreexpresión de P53 y C-erb-2 como factor pronostico de progresión y supervivencia en pacientes con Tm. de pelvis renal y uréter. Método: Análisis retrospectivo de historias clínicas y estudios anatomopatológicos e inmunohistoquímicos de 61 pacientes sometidos a cirugía por T.U.S. El estudio inmunohistoquímico de las muestras se realizó con técnicas de STREPTAVIDINA-BIOTINA-PEROXIDASA mediante KIT LASAB (DAKO). El análisis de los resultados, se realizó mediante tablas de contingencias 2x2 con cálculos de Chi2 de PEARSON y análisis de residuos para variables cualitativas, el nivel de confianza fue de P<0,05, para la interrelación de variables múltiples se utilizó análisis multivariantes de COX y curvas de supervivencias. Resultados: La mayor sobreexpresión de P53 estuvo relacionada con la muerte tumor dependiente (P<0,001).Teniendo estos pacientes comprometida su supervivencia a largo plazo. La sobreexpresión de C-erb-2 no se relaciona estadísticamente con la proliferación, ni muerte tumor dependiente de los T.U.S. Conclusiones: En nuestra serie la sobreexpresión P53 es de utilidad pronóstica en los T.U.S., mientras que la expresión C-erb-2 no tuvo valor pronóstico en estos tumores (AU)


Subject(s)
Middle Aged , Adult , Aged , Aged, 80 and over , Male , Female , Humans , Gene Expression Regulation, Neoplastic , Proportional Hazards Models , Survival Analysis , Genes, p53 , Receptor, ErbB-2 , Genes, erbB-2 , Disease Progression , Prognosis , Retrospective Studies , Carcinoma, Transitional Cell , Immunoenzyme Techniques , Kidney Pelvis , Ureteral Neoplasms , Tumor Suppressor Protein p53 , Neoplasm Proteins , Kidney Neoplasms
3.
Arch Esp Urol ; 55(5): 503-8, 2002 Jun.
Article in Spanish | MEDLINE | ID: mdl-12174416

ABSTRACT

OBJECTIVE: To analyze the influence of personal and histopathological factors as prognostic variables in the evolution of upper urothelial tumors submitted to radical surgery. METHODS: Multifactorial retrospective study of a series of 61 patients submitted to radical surgery for upper urinary tract transitional cell tumors. Patient habits and histopathological factors are analyzed. The statistical significance of the different factors was analyzed using the Pearson chi-square test for the qualitative variables, with analysis of the residuals and Kaplan-Meier survival curves and statistical validation with the Mantel Cox test. The level of significance was p < 0.05. RESULTS: A statistically significant correlation was found for tumor-related death and pathological stage, positive lymphadenectomy and positive lymphadenopathy on the CT (p < 0.05). The presence or absence of a history of smoking was not available for all patients and was therefore not evaluable. The most frequent reason for consultation was hematuria (39%). Tumor growth was mostly of the papillary type (79%), localization was mostly in the renal pelvis (30%) and the most frequent procedure was nephroureterectomy without endoscopic detachment (60%). CONCLUSIONS: The pathological stage and a positive lymphadenectomy or the presence of positive lymphadenopathies on the CT were found to be prognostic factors in urothelial tumors of the upper urinary tract.


Subject(s)
Carcinoma, Transitional Cell/mortality , Kidney Neoplasms/mortality , Ureteral Neoplasms/mortality , Adult , Aged , Aged, 80 and over , Carcinoma, Transitional Cell/pathology , Carcinoma, Transitional Cell/surgery , Comorbidity , Female , Follow-Up Studies , Humans , Kidney Neoplasms/pathology , Kidney Neoplasms/surgery , Life Tables , Lymph Node Excision , Male , Middle Aged , Neoplasm Staging , Nephrectomy , Prognosis , Proportional Hazards Models , Retrospective Studies , Smoking/epidemiology , Survival Analysis , Treatment Outcome , Ureteral Neoplasms/pathology , Ureteral Neoplasms/surgery
4.
Arch. esp. urol. (Ed. impr.) ; 55(5): 503-508, jun. 2002.
Article in Es | IBECS | ID: ibc-13245

ABSTRACT

Objetivo: Valorar la influencia de factores personales e histopatológicos como variables pronósticas en la evolución de los tumores uroteliales alto sometidos a cirugía radical. Método: Estudio retrospectivo multifactorial de una serie de 61 pacientes sometidos a cirugía radical por tumores transicionales de vías altas, analizando hábitos personales y factores histopatológicos. Para valorar la significación estadística de los diferentes factores se empleó el test de Chi-cuadrado de Pearson para variables cualitativas, con análisis de residuos y análisis de las curvas de supervivencia de Kaplan-Meyer y validación estadística según el test de Mantel Cox, siendo el nivel de significación: P menor del 5 por ciento. Resultados: Encontramos relación estadísticamente significativa entre muerte tumor-dependiente y estadío patológico, linfadenectomía positiva así como con adenopatías positivas en la TC previa (P menor de 0,05. La presencia o ausencia del antecedente de hábito tabáquico no figuraba en todos los pacientes por lo que no era valorable. La consulta más frecuente fue por hematuria (39 por ciento). El crecimiento era mayoritariamente de tipo papilar (79 por ciento), y localización mayoritaria en pelvis renal (30 por ciento) y la intervención más frecuente fue nefroureterectomía sin desinserción endoscópica (60 por ciento).Conclusiones: El estadío patológico y dentro de este la presencia de linfadenectomía positiva o la presencia de adenopatías positivas en la TC previa, constituyen factores pronósticos en la evolución de tumores uroteliales de vías altas (AU)


Subject(s)
Middle Aged , Adult , Aged , Aged, 80 and over , Male , Female , Humans , Tobacco Use Disorder , Proportional Hazards Models , Life Tables , Comorbidity , Survival Analysis , Treatment Outcome , Nephrectomy , Prognosis , Retrospective Studies , Carcinoma, Transitional Cell , Lymph Node Excision , Follow-Up Studies , Ureteral Neoplasms , Neoplasm Staging , Kidney Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL
...